Profile picture of Reuters
Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...
reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
Novartis begins tender offer for cancer-focused MorphoSys
Profile picture of BÖRSE ONLINE
On the way to new record highs, some German shares have gained more than others. These are the five best stocks in the DAX ... Show more   ow.ly/vZk250QI8MA
Profile picture of Handelsblatt
Biotech: Morphosys writes deep red figures before takeover by Novartis: Group loss increased to just under 190 million euros in 2023 from a good 151 million a ...
handelsblatt.com/unternehmen/industrie/biotech-morphosys-schreibt-vor-uebernahme-durch-novartis-tiefrote-zahlen/100023761.html
Biotech: Morphosys writes deep red figures before takeover by Novartis
Profile picture of Bloomberg
MorphoSys Gains on Report Novartis in Talks to Buy Drugmaker: MorphoSys AG shares surged after a report that Novartis AG is in advanced talks to buy the German ...
bloomberg.com/news/articles/2024-02-05/morphosys-surges-on-report-novartis-is-in-talks-to-buy-drugmaker
MorphoSys Gains on Report Novartis in Talks to Buy Drugmaker
Profile picture of BÖRSE ONLINE
After Novartis's takeover offer to Morphosys, other German companies could find themselves in the sights of corporate hunters ... Show more   ow.ly/AVzh50QCFa7
Profile picture of Handelsblatt
Biotech company: Federal Cartel Office approves takeover of Morphosys: The pharmaceutical giant Novartis announced its purchase of the German biotech company for ...
handelsblatt.com/unternehmen/industrie/biotechfirma-bundeskartellamt-gibt-uebernahme-von-morphosys-frei/100023231.html
Biotech company: Federal Cartel Office approves takeover of Morphosys
Profile picture of DER AKTIONÄR
DAX remains strong: E.on, Adidas, Zalando, Volkswagen, Porsche and Deutsche Bank in focus
deraktionaer.de/artikel/indizes/dax-weiter-stark-eon-adidas-zalando-volkswagen-porsche-und-deutsche-bank-im-fokus-20352793.html
DAX remains strong: E.on, Adidas, Zalando, Volkswagen, Porsche and ...
Profile picture of Frankfurter Allgemeine Zeitung
Profile picture of DER AKTIONÄR
Profile picture of Wirtschaftswoche
L'Occitane, MorphoSys, Antofagasta: These are the investment tips of the week: Antofagasta arouses desire, Ametek is one of the most stable long-term investments ...
wiwo.de/my/finanzen/geldanlage/loccitane-morphosys-antofagasta-das-sind-die-anlagetipps-der-woche/29655316.html
L'Occitane, MorphoSys, Antofagasta: These are the investment tips of the ...
Profile picture of DER AKTIONÄR
Morphosys: Is the rise now coming before the exit?: Morphosys could soon be promoted to the MDAX, but is about to be taken over by Novartis.
deraktionaer.de/artikel/pharma-biotech/morphosys-kommt-jetzt-der-aufstieg-vor-dem-ausstieg-20350352.html
Morphosys: Is the rise now coming before the exit?
Profile picture of DER AKTIONÄR
DAX remains strong: Siemens Energy, Heidelberger Druck, Teamviewer, Alibaba, Deutsche Börse, Disney, Paypal, Qiagen, Morphosys and Renk in focus - what's ...
deraktionaer.de/artikel/indizes/dax-weiter-stark-siemens-energy-heidelberger-druck-teamviewer-alibaba-deutsche-boerse-disney-paypal-qiagen-morphosys-und-renk-im-fokus-das-ist-heute-wichtig-20349803.html
DAX remains strong: Siemens Energy, Heidelberger Druck, Teamviewer ...
Profile picture of DER AKTIONÄR
First Morphosys, now Qiagen? Betaville with new rumors: Novartis reaches out to German biotech firm Morphosys.
deraktionaer.de/artikel/pharma-biotech/erst-morphosys-jetzt-qiagen-betaville-mit-neuen-geruechten-20349781.html
First Morphosys, now Qiagen? Betaville with new rumors
Profile picture of DER AKTIONÄR
Morning markets: BYD, Palantir, McDonald's, Super Micro Computer, Infineon, MorphoSys, UniCredit
15:01
Profile picture of BÖRSE ONLINE
DAX heads straight for record highs in the new year - Also in focus: Lufthansa and MorphoSys shares
boerse-online.de/nachrichten/rohstoffe/so-startet-der-dax-in-das-boersenjahr-2024-ausserdem-im-fokus-die-aktien-von-sartorius-und-asml-20346678.html
DAX heads straight for record highs in the new year - Also in focus: ...
Quick Glance: DAX Hits Record High in New Year
  • The DAX rose on the first trading day of 2024 after reaching a record high last year.

  • The MDAX had an eight percent increase last year, significantly less than the DAX.

  • 2023 was the second-best year for the DAX in the past ten years, with a gain of around 20 percent.

  • The continued recovery rally led to the stocks of MorphoSys reaching a new high on Tuesday since December 2021.
Profile picture of Handelsblatt
Morphosys: This graphic shows how short sellers dominate the price: Morphosys shares are rising to their highest level in two years for no apparent reason ...
handelsblatt.com/finanzen/maerkte/aktien/morphosys-diese-grafik-zeigt-wie-shortseller-den-kurs-dominieren/100007604.html
Morphosys: This graphic shows how short sellers dominate the price
Profile picture of BÖRSE ONLINE
DAX rally continues - Shares in Vonovia and Siemens Energy up almost double digits
boerse-online.de/nachrichten/rohstoffe/dax-bei-17000-punkten-morphosys-und-apple-im-fokus-20345778.html
DAX rally continues - Shares in Vonovia and Siemens Energy up almost ...
Profile picture of DER AKTIONÄR
RAPID: Morphosys shares suddenly make a giant leap: The shares of the biotechnology company Morphosys suddenly jumped up in the late afternoon on Friday ...
deraktionaer.de/artikel/aktien/eil-morphosys-aktie-macht-ploetzlich-riesensprung-20348790.html
RAPID: Morphosys shares suddenly make a giant leap
Profile picture of BÖRSE ONLINE
MorphoSys shares fall in double digits: That's what's behind it: The share of the biopharmaceutical company Morphosys was the big loser in the SDAX on Friday ...
boerse-online.de/nachrichten/aktien/morphosys-aktie-schmiert-zweistellig-ab-das-steckt-dahinter-20348113.html
MorphoSys shares fall in double digits: That's what's behind it
Profile picture of DER AKTIONÄR
Profile picture of Handelsblatt
Morphosys: share price rises - details on hopeful Pelabresib: An initial study on the cancer drug disappointed investors and caused Morphosys shares to plummet ...
handelsblatt.com/finanzen/maerkte/aktien/morphosys-aktie-steigt-details-zu-hoffnungstraeger-pelabresib/100002956.html
Morphosys: share price rises - details on hopeful Pelabresib
Profile picture of Handelsblatt
Biotech company Morphosys raises 100 million euros via capital increase: Morphosys wants to finance clinical trials and has raised fresh money from institutional ...
handelsblatt.com/finanzen/maerkte/aktien/biotechfirma-morphosys-nimmt-ueber-kapitalerhoehung-100-millionen-euro-ein/100003369.html
Biotech company Morphosys raises 100 million euros via capital increase
Profile picture of DER AKTIONÄR
Morphosys: Shares are stepping on the gas again - new 2-year high: Morphosys shares start the year at a premium of 6.3%, supported by positive study data and ...
deraktionaer.de/artikel/pharma-biotech/morphosys-aktie-gibt-schon-wieder-gas-neues-2-jahreshoch-20346687.html
Morphosys: Shares are stepping on the gas again - new 2-year high
Profile picture of DER AKTIONÄR
Morphosys, Hypoport & Co: These are the top winners in the SDAX 2023: 2023 was a turbulent but good year on the stock market.
deraktionaer.de/artikel/maerkte-forex-zinsen/morphosys-hypoport-co-das-sind-die-top-gewinner-im-sdax-2023-20346603.html
Morphosys, Hypoport & Co: These are the top winners in the SDAX 2023
Profile picture of Frankfurter Allgemeine Zeitung
Stock market week: With Bayer, Morphosys and Teamviewer on the stock market sled: The Dax closes at 16,029 points and is on course for a record ...
faz.net/aktuell/finanzen/mit-bayer-morphosys-und-teamviewer-auf-dem-boersenschlitten-19337927.html
Stock market week: With Bayer, Morphosys and Teamviewer on the stock ...
Profile picture of Die Presse
Morphosys: Best value in the SDAX: If the cancer drug Pelabresib is approved, there will be further surcharges for the biotech company.
diepresse.com/17927517/morphosys-bester-wert-im-sdax
Morphosys: Best value in the SDAX
Profile picture of DER AKTIONÄR
Morphosys remains strong - “massive stress factor vanished into thin air”: Morphosys shares continue to gain strength, with an increase of 3.7% to 33.95 euros ...
deraktionaer.de/artikel/pharma-biotech/morphosys-weiter-stark-massiver-belastungsfaktor-in-luft-aufgeloest-20346027.html
Morphosys remains strong - “massive stress factor vanished into thin air”
Profile picture of DER AKTIONÄR
Profile picture of Handelsblatt
Biotech company: MorphoSys hopeful achieves targets in pivotal trial: The drug for treating a rare malignant disease of the bone marrow has passed the decisive ...
handelsblatt.com/unternehmen/industrie/biotechunternehmen-hoffnungstraeger-von-morphosys-erreicht-ziele-in-entscheidender-studie/29512994.html
Biotech company: MorphoSys hopeful achieves targets in pivotal trial
Profile picture of DER AKTIONÄR
DAX with new record: Sartorius, QIagen, Siemens, RWE, Morphosys and Uniper the top winners, Bayer, Siemens Energy, Zalando and Encavis weak
deraktionaer.de/artikel/indizes/dax-mit-neuem-rekord-sartorius-qiagen-siemens-rwe-morphosys-und-uniper-die-top-gewinner-bayer-siemens-energy-zalando-und-encavis-schwach-20345489.html
DAX with new record: Sartorius, QIagen, Siemens, RWE, Morphosys and Uniper ...
Profile picture of DER AKTIONÄR
DAX continues to rise: BASF, Jenoptik, Tesla, Meta, Morphosys, Bayer, Siemens and BioNTech in focus - this is important today
deraktionaer.de/artikel/indizes/dax-steigt-weiter-basf-jenoptik-tesla-meta-morphosys-bayer-siemens-und-biontech-im-fokus-das-ist-heute-wichtig-20344693.html
DAX continues to rise: BASF, Jenoptik, Tesla, Meta, Morphosys, Bayer ...
Profile picture of DER AKTIONÄR
Morphosys: The hunt continues - already 48 percent plus since the low: Morphosys shares recover from losses, gaining 48%, despite mixed opinions about the ...
deraktionaer.de/artikel/pharma-biotech/morphosys-aufjoljagd-geht-weiter-schon-48-prozent-plus-seit-dem-tief-20344631.html
Morphosys: The hunt continues - already 48 percent plus since the low
Profile picture of DER AKTIONÄR
Morphosys: Plus 26 percent since the low - will the race to catch up continue?: Morphosys shares are recovering despite mixed trial data for the drug Pelabresib ...
deraktionaer.de/artikel/pharma-biotech/morphosys-plus-26-prozent-seit-dem-tief-geht-die-aufholjagd-weiter-20344468.html
Morphosys: Plus 26 percent since the low - will the race to catch up ...
Profile picture of DER AKTIONÄR
Morphosys: target price 10 euros or 47 euros?: Morphosys shares are trying to stabilize after sell-offs. Failures in secondary endpoints in a phase 3 study of ...
deraktionaer.de/artikel/pharma-biotech/morphosys-kursziel-10-euro-oder-47-euro-20344182.html
Morphosys: target price 10 euros or 47 euros?
Profile picture of DER AKTIONÄR
Nvidia is cheap, SMA Solar is dirt cheap, Freyr Battery is being given away: Once again, Nvidia has presented figures that seem to come from another world.
deraktionaer.de/artikel/aktien/nvidia-ist-guenstig-sma-solar-spottbillig-freyr-battery-wird-verschenkt-20344067.html
Nvidia is cheap, SMA Solar is dirt cheap, Freyr Battery is being given ...
Profile picture of DER AKTIONÄR
maydorn's opinion: Nvidia, MorphoSys, Bayer, Tesla, BYD, SMA, JinkoSolar, Freyr, Standard Lithium
28:20
Profile picture of DER AKTIONÄR
DAX expected to be slightly higher: Bayer, Morphosys, Siemens Energy, Rheinmetall, Nordex, Teamviewer and Nvidia in focus - this is important today
deraktionaer.de/artikel/indizes/dax-leicht-im-plus-erwartet-bayer-morphosys-siemens-energy-rheinmetall-nordex-teamviewer-und-nvidia-im-fokus-das-ist-heute-wichtig-20343889.html
DAX expected to be slightly higher: Bayer, Morphosys, Siemens Energy ...
Profile picture of BÖRSE ONLINE
DAX rally now over? Shares from Siemens, Zalando and BASF in focus: Was that the end of the DAX rally or can investors look forward to further price increases? ...
boerse-online.de/nachrichten/rohstoffe/dax-bald-bei-16000-punkten-aktien-von-morphosys-und-hellofresh-im-fokus-20343560.html
DAX rally now over? Shares from Siemens, Zalando and BASF in focus
Profile picture of DER AKTIONÄR
DAX hardly changed after strong development: Siemens, Alibaba, Walmart, CTS Eventim, Cisco, Ceconomy, K+S, Morphosys and HelloFresh in focus - this is ...
deraktionaer.de/artikel/indizes/dax-nach-starker-entwicklung-kaum-veraendert-erwartet-siemens-alibaba-walmart-cts-eventim-cisco-ceconomy-ks-morphosys-und-hellofresh-im-fokus-das-ist-heute-wichtig-20343542.html
DAX hardly changed after strong development: Siemens, Alibaba, Walmart ...
Profile picture of DER AKTIONÄR
DAX friendly expected: Siemens Energy, Infineon, Dermapharm, SFC Energy, Morphosys, Cisco Systems, Airbus and Evotec in focus - this is important today
deraktionaer.de/artikel/indizes/dax-freundlich-erwartet-siemens-energy-infineon-dermapharm-sfc-energy-morphosys-cisco-systems-airbus-und-evotec-im-fokus-das-ist-heute-wichtig-20343440.html
DAX friendly expected: Siemens Energy, Infineon, Dermapharm, SFC Energy ...
Profile picture of DER AKTIONÄR
Markets in the morning: BioNTech, Birkenstock, DAX, Vonovia, Commerzbank, Lanxess, Morphosys, K+S
10:57
Profile picture of DER AKTIONÄR
Morphosys: Shortly before new annual high: Morphosys shares are rising again and are approaching a new annual high. Higher trading volume and upcoming quarterly ...
deraktionaer.de/artikel/aktien/morphosys-kurz-vor-neuem-jahreshoch-20342759.html
Morphosys: Shortly before new annual high
Profile picture of DER AKTIONÄR
Full throttle biotech: pipeline ensures enormous price potential: The German company's hope is about to publish its development figures - This could start the ...
deraktionaer.de/artikel/pharma-biotech/vollgas-biotech-pipeline-sorgt-fuer-enormes-kurspotenzial-20342670.html
Full throttle biotech: pipeline ensures enormous price potential
Profile picture of DER AKTIONÄR
DAX hardly changed, USA and China with losses: Sartorius, JPMorgan, Citigroup, Fraport, Volkswagen, Rheinmetall, Zalando and Morphosys in focus - this is ...
deraktionaer.de/artikel/indizes/dax-kaum-veraendert-usa-und-china-mit-verlusten-sartorius-jpmorgan-citigroup-fraport-volkswagen-rheinmetall-zalando-und-morphosys-im-fokus-das-ist-heute-wichtig-20341055.html
DAX hardly changed, USA and China with losses: Sartorius, JPMorgan ...
Profile picture of BÖRSE ONLINE
Stock market: DAX shortly before 16,000 points thanks to the ECB and the witches' sabbath - Stocks from Vonovia, Rheinmetall, BayWa and MorphoSys in focus
boerse-online.de/nachrichten/rohstoffe/boerse-so-startet-der-dax-in-den-hexensabbat-aktien-von-baywa-und-morphosys-im-fokus-20339477.html
Stock market: DAX shortly before 16,000 points thanks to the ECB and the ...
Profile picture of BÖRSE ONLINE
Stock market: DAX curbs losses, Wall Street appears strong: US inflation and shares of Siemens Energy and Adidas in focus
boerse-online.de/nachrichten/rohstoffe/boerse-warum-faellt-der-dax-schon-wieder-aktien-von-morphosys-und-hamburger-hafen-im-fokus-20339311.html
Stock market: DAX curbs losses, Wall Street appears strong: US inflation ...
Profile picture of DER AKTIONÄR
DAX fails at 16,000 points - BASF increases - Porsche jump into plus - Goldman Sachs switches sides at Morphosys - Hornbach buckles
deraktionaer.de/artikel/maerkte-forex-zinsen/dax-scheitert-bei-16000-punkten-basf-legt-zu-porsche-springen-in-plus-goldman-sachs-wechselt-bei-morphosys-die-seite-hornbach-knickt-ein-20339540.html
DAX fails at 16,000 points - BASF increases - Porsche jump into plus - ...
Profile picture of DER AKTIONÄR
Morphosys with price jump: Goldman Sachs increases price target by 168 percent: Morphosys shares rise 7.6% after upgrade by Goldman Sachs.
deraktionaer.de/artikel/pharma-biotech/morphosys-mit-kurssprung-goldman-sachs-erhoeht-kursziel-um-168-prozent-20339485.html
Morphosys with price jump: Goldman Sachs increases price target by 168 ...
Profile picture of DER AKTIONÄR
DAX expected to be significantly higher after ECB interest rate decision: Big expiration day today, LSE, Morphosys, Salesforce, Oracle, Microsoft, Arm, H&M ...
deraktionaer.de/artikel/indizes/dax-nach-ezb-zinsentscheid-deutlich-im-plus-erwartet-heute-grosser-verfallstag-lse-morphosys-salesforce-oracle-microsoft-arm-hm-volkswagen-und-adobe-im-fokus-das-ist-heute-wichtig-20339460.html
DAX expected to be significantly higher after ECB interest rate decision: ...
Profile picture of DER AKTIONÄR
Profile picture of DER AKTIONÄR
DAX & Co with slight losses: Commerzbank, Deutsche Bank, FMC and Fresenius under pressure, BMW, Porsche AG, Continental, Stabilus and Morphosys the top winners
deraktionaer.de/artikel/indizes/dax-co-mit-leichten-verlusten-commerzbank-deutsche-bank-fmc-und-fresenius-unter-druck-bmw-porsche-ag-continental-stabilus-und-morphosys-die-top-gewinner-20338891.html
DAX & Co with slight losses: Commerzbank, Deutsche Bank, FMC and Fresenius ...
Profile picture of DER AKTIONÄR
Morphosys on the up: Massive buy-signal ahead: Morphosys is one of the top performers in the year to date.
deraktionaer.de/artikel/pharma-biotech/morphosys-im-aufwind-massives-kaufsignal-voraus-20338214.html
Morphosys on the up: Massive buy-signal ahead
Profile picture of DER AKTIONÄR
Morphosys: Double buy recommendation: The biotech company Morphosys was able to present solid figures for the second quarter this trading week.
deraktionaer.de/artikel/pharma-biotech/morphosys-doppelte-kaufempfehlung-20337523.html
Morphosys: Double buy recommendation
Profile picture of DER AKTIONÄR
Morphosys: It's going to be exciting tonight: Morphosys will publish its Q2 figures on Wednesday evening.
deraktionaer.de/artikel/aktien/morphosys-heute-abend-wird-es-spannend-20337342.html
Morphosys: It's going to be exciting tonight
Profile picture of DER AKTIONÄR
DAX higher expected: E.on, Brenntag, Hannover Re, TUI, Continental, Morphosys, Disney, BMW, Mercedes-Benz, Volkswagen and Novo Nordisk in focus - this is ...
deraktionaer.de/artikel/indizes/dax-hoeher-erwartet-eon-brenntag-hannover-rueck-tui-continental-morphosys-disney-bmw-mercedes-benz-volkswagen-und-novo-nordisk-im-fokus-das-ist-heute-wichtig-20337298.html
DAX higher expected: E.on, Brenntag, Hannover Re, TUI, Continental ...
Profile picture of BÖRSE ONLINE
Derivatives Depot - Exchange in the bonus cap area: Volkswagen is kicked out: A small loss was accepted on the position on Volkswagen before it could turn larger ...
boerse-online.de/nachrichten/zertifikate/derivatedepot-austausch-im-bonus-cap-bereich-volkswagen-fliegt-raus-20337043.html
Derivatives Depot - Exchange in the bonus cap area: Volkswagen is kicked ...
Profile picture of DER AKTIONÄR
Morphosys: price target 12.50 euros? It doesn't matter!: The share of the biotechnology company Morphosys is one of the absolute high-flyers on the German share ...
deraktionaer.de/artikel/pharma-biotech/morphosys-kursziel-1250-euro-egal-20336084.html
Morphosys: price target 12.50 euros? It doesn't matter!
Profile picture of BÖRSE ONLINE
Stock market: DAX can recover, Wall Street friendly - Focus on luxury crash and shares of Deutsche Bank and Commerzbank
boerse-online.de/nachrichten/rohstoffe/boerse-so-startet-der-dax-in-die-handelswoche-20335777.html
Stock market: DAX can recover, Wall Street friendly - Focus on luxury ...
Profile picture of DER AKTIONÄR
BREAKING: DAX defends 16,000 point mark - Deutsche Bank top, Infineon flop, Morphosys with a big plus
deraktionaer.de/artikel/indizes/breaking-dax-verteidigt-16000-punkte-marke-deutsche-bank-top-infineon-flop-morphosys-mit-dickem-plus-20335837.html
BREAKING: DAX defends 16,000 point mark - Deutsche Bank top, Infineon flop ...
Profile picture of DER AKTIONÄR
Morphosys: Next stop - 30 euros: The cops are in charge!
deraktionaer.de/artikel/aktien/morphosys-naechster-halt-30-euro-20335266.html
Morphosys: Next stop - 30 euros
Profile picture of DER AKTIONÄR
Profile picture of DER AKTIONÄR
Profile picture of DER AKTIONÄR
Markets in the morning: Adobe, Alibaba, Deutsche Bank, Hugo Boss, H&M, Zalando, MorphoSys
8:04
Profile picture of DER AKTIONÄR